Virus | Descriptive name | VV gene deactivation (recombination site) | CD55 expression | VV TM used for CD55 expression | VV TM a.a. position | Marker genes |
JX-594 | VV-GM-CSF | J2R | No | N/A | N/A | LacZ |
SJ-610 | VV-GM-CSF | J2R | No | N/A | N/A | Luc-GFP |
SJ-601 | VV-GM-CSF-CD55 D8 | J2R | Yes | D8L | 276–304 | Luc-GFP |
SJ-604 | VV-GM-CSF-CD55 A16 | J2R | Yes | A16L | 343–377 | Luc-GFP |
SJ-605 | VV-GM-CSF-CD55 F9 | J2R | Yes | F9L | 176–212 | Luc-GFP |
SJ-606 | VV-GM-CSF-CD55 G9 | J2R | Yes | G9R | 320–340 | Luc-GFP |
SJ-607 | VV-GM-CSF-CD55 H3 | J2R | Yes | H3L | 285–324 | Luc-GFP |
SJ-608 | VV-GM-CSF-CD55 L1 | J2R | Yes | L1R | 184–250 | Luc-GFP |
All viruses were derived from the Wyeth strain of vaccinia virus and all expressed GM-CSF. An expression cassette including GM-CSF was inserted into the thymidine kinase (J2R) gene of the vaccinia genome to inactivate this gene. The CD55 gene was fused with the transmembrane domain of one of the vaccinia virus membrane proteins, as indicated.
GFP, green fluorescent protein; GM-CSF, granulocyte-macrophage colony-stimulating factor; LacZ, β-galactosidase; Luc, luciferase; N/A, not applicable; TM, transmembrane domain; VV, vaccinia virus.